Back
Avalo Therapeutics Quote, Financials, Valuation and Earnings
Sponsored
AVTX
Sponsored
Elon's Secret "A.I. 2.0" Project
Click here now to discover how to claim a stake in Elon's "A.I. 2.0" project
Sell
42
AVTX
Avalo Therapeutics
Last Price:
16.50
Seasonality Move:
-13.32%
7 Day Trial
ALL ACCESS PASS
$
7
My #1 Coin is...
All the details are on the next page.Avalo Therapeutics Price Quote
$16.50
-0.38 (-2.25%)
(Updated: April 30, 2024 at 1:30 PM ET)
Avalo Therapeutics Key Stats
Sell
42
Avalo Therapeutics (AVTX)
is a Sell
Day range:
$15.68 - $17.49
52-week range:
$3.95 - $1,130.40
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.42
P/B ratio:
2.39%
Volume:
81.8K
Avg. volume:
1.4M
1-year change:
-97.58%
Market cap:
$17.5M
Revenue:
$1.9M
EPS:
$-382.19
How Much Does Avalo Therapeutics Make?
-
How Much Are Avalo Therapeutics's Sales Annually?
AVTX Revenues are $1.9M -
How Much Profit Does Avalo Therapeutics's Make A Year?
AVTX net income is -$31.5M
Is Avalo Therapeutics Growing As A Company?
-
What Is Avalo Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.36% -
What Is Avalo Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Avalo Therapeutics Stock Price Performance
-
Did Avalo Therapeutics Stock Go Up Last Month?
Avalo Therapeutics share price went down by -22.39% last month -
Did AVTX's Share Price Rise Over The Last Year?
AVTX share price fell by -97.58% over the past 1 year
What Is Avalo Therapeutics 52-Week High & Low?
-
What Is Avalo Therapeutics’s 52-Week High Share Price?
Avalo Therapeutics has traded as high as $1,130.40 over the past 52 weeks -
What Is Avalo Therapeutics’s 52-Week Low Share Price?
Avalo Therapeutics has traded as low as $3.95 over the past 52 weeks
Avalo Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Avalo Therapeutics?
-
How Much Debt Does Avalo Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Avalo Therapeutics Have?
Cash and short term investments quarterly total is $7.4M -
What Is Avalo Therapeutics’s Book Value Per Share?
Book value per share is 9.11
Is Avalo Therapeutics Cash Flow Positive?
-
What Is AVTX Cash Flow From Operations?
Cash flow from operations (TTM) is -$30.7M -
What Is Avalo Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $25M -
What Is Avalo Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$133K
Avalo Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
AVTX return on invested capital is -308.38% -
What Is Avalo Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -109.45% -
What Is AVTX Return On Equity?
ROE is a measure of profitability and is 0%
Avalo Therapeutics Earnings Date & Stock Price
-
What Is Avalo Therapeutics's Stock Price Today?
A single share of AVTX can be purchased today for 16.88 -
What Is Avalo Therapeutics’s Stock Symbol?
Avalo Therapeutics trades on the nasdaq under the ticker symbol: AVTX -
When Is Avalo Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Avalo Therapeutics is scheduled on May 3, 2024 -
When Is AVTX's next ex-dividend date?
Avalo Therapeutics's next ex-dividend date is April 30, 2024 -
How To Buy Avalo Therapeutics Stock?
You can buy Avalo Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Avalo Therapeutics Competitors
-
Who Are Avalo Therapeutics's Competitors?
Below is a list of companies who compete with Avalo Therapeutics or are related in some way:
Avalo Therapeutics Dividend Yield
Data Unavailable
Avalo Therapeutics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 0% |
Revenue: | -36.27% | 90.33% |
Analyst Recommendations
Buy Recommendations: | 1 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 35.00 |
Upside from Last Price: | 107.35% |